Home » Topics » Regulatory » Patents

Patents
RSS

Compounds for cardiovascular diseases described by BMS

Jan. 16, 1998

Anti-IL-4 antibodies from Schering-Plough

Jan. 16, 1998

Novel polyspecific antibody-agent conjugates from Immunomedics

Jan. 16, 1998

Novel tumor vaccine technology described by U.S. researchers

Jan. 15, 1998

New PAF antagonists disclosed by Korean investigators

Jan. 15, 1998

Modulators of muscarinic receptors claimed by Lilly for AD, psychosis

Jan. 15, 1998

Phthalazine AMPA receptor antagonists claimed by Schering AG

Jan. 15, 1998

Prodrugs of COX-2 inhibitors prepared at Searle

Jan. 15, 1998

Lilly describes new glycopeptides active against VRE

Jan. 15, 1998

Pharma Mar discovers new antitumor heptapeptide from Australian ascidian

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.